erythrosine has been researched along with Cardiac Diseases in 7 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperhomocysteinemia is a risk factor for cardiovascular disease, stroke, and thrombosis; however, the mechanisms by which homocysteine triggers these dysfunctions are not fully understood." | 3.77 | Homocysteine induces oxidative-nitrative stress in heart of rats: prevention by folic acid. ( da Cunha, AA; da Cunha, MJ; Kolling, J; Scherer, EB; Wyse, AT, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kolling, J | 1 |
| Scherer, EB | 1 |
| da Cunha, AA | 1 |
| da Cunha, MJ | 1 |
| Wyse, AT | 1 |
| SPEAR, GS | 1 |
| KIHARA, I | 1 |
| Sin, KK | 1 |
| Chan, CP | 1 |
| Leung, WM | 1 |
| Seydack, M | 1 |
| Renneberg, R | 1 |
| Mizobe, A | 1 |
| Murai, S | 1 |
| Mizushima, N | 1 |
| Al-Hakiem, MH | 1 |
| Simon, M | 1 |
| Mahmod, S | 1 |
| Landon, J | 1 |
| Chacon, E | 1 |
| Acosta, D | 1 |
| Yannuzzi, LA | 1 |
| Rohrer, KT | 1 |
| Tindel, LJ | 1 |
| Sobel, RS | 1 |
| Costanza, MA | 1 |
| Shields, W | 1 |
| Zang, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Macular Perfusion Changes in Proliferative Diabetic Retinopathy Following Anti-VEGF Therapy Versus Targeted and Pan-retinal Photocoagulation Using Optical Coherence Tomography Angiography[NCT04674254] | Phase 4 | 43 participants (Actual) | Interventional | 2021-03-30 | Active, not recruiting | ||
| Evaluation of the Effect of Repeated Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using Optical Coherence Tomography Angiography[NCT03246152] | Phase 4 | 31 participants (Actual) | Interventional | 2017-10-23 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Correlation of BCVA change with degree of capillary non-perfusion before and after injections (NCT03246152)
Timeframe: At baseline and after 3-6 consecutive monthly injections.
| Intervention | Logmar (Mean) |
|---|---|
| Bevacizumab Group | -0.21 |
Effect of repeated intravitreal Anti-VEGF injections on Foveal Avascular Zone (FAZ) area measured using the freehand tool of ImageJ (NCT03246152)
Timeframe: At baseline and after 3-6 consecutive monthly injections.
| Intervention | mm^2 (Mean) |
|---|---|
| Bevacizumab Group | 0.03 |
Effect of repeated intravitreal Anti-VEGF injections on macular capillary density using the change in the skeletonized vascular density and fractal dimension measured by ImageJ (NCT03246152)
Timeframe: At baseline and after 3-6 consecutive monthly injections.
| Intervention | percentage of vascularity (Mean) |
|---|---|
| Bevacizumab Group | -2.5 |
1 review available for erythrosine and Cardiac Diseases
| Article | Year |
|---|---|
Fluorescein angiography complication survey.
Topics: Fluorescein; Fluorescein Angiography; Fluoresceins; Health Surveys; Heart Diseases; Humans; Nausea; | 1986 |
Fluorescein angiography complication survey.
Topics: Fluorescein; Fluorescein Angiography; Fluoresceins; Health Surveys; Heart Diseases; Humans; Nausea; | 1986 |
Fluorescein angiography complication survey.
Topics: Fluorescein; Fluorescein Angiography; Fluoresceins; Health Surveys; Heart Diseases; Humans; Nausea; | 1986 |
Fluorescein angiography complication survey.
Topics: Fluorescein; Fluorescein Angiography; Fluoresceins; Health Surveys; Heart Diseases; Humans; Nausea; | 1986 |
6 other studies available for erythrosine and Cardiac Diseases
| Article | Year |
|---|---|
Homocysteine induces oxidative-nitrative stress in heart of rats: prevention by folic acid.
Topics: Animals; Antioxidants; Catalase; Disease Models, Animal; Female; Fluoresceins; Folic Acid; Heart Dis | 2011 |
THE GLOMERULUS IN CYANOTIC CONGENITAL HEART DISEASE: AN IMMUNOFLUORESCENT STUDY.
Topics: Cyanosis; Fluoresceins; Fluorescent Antibody Technique; gamma-Globulins; Heart Defects, Congenital; | 1964 |
Fluorogenic nanocrystals for highly sensitive detection of C-reactive protein.
Topics: Aged; Biomarkers; C-Reactive Protein; Female; Fluoresceins; Fluoroimmunoassay; Heart Diseases; Human | 2006 |
Fluorescein studies of hypertensive retinopathy.
Topics: Adult; Animals; Arteriosclerosis; Blood Flow Velocity; Blood Pressure; Diabetic Retinopathy; Exudate | 1967 |
Fluoroimmunoassay of digitoxin in serum.
Topics: Digitoxin; Fluoresceins; Heart Diseases; Humans; Immunoassay; Radioimmunoassay; Reference Values | 1982 |
Mitochondrial regulation of superoxide by Ca2+: an alternate mechanism for the cardiotoxicity of doxorubicin.
Topics: Animals; Biological Transport; Calcium; Cell Survival; Cells, Cultured; Doxorubicin; Fluoresceins; F | 1991 |